mk 0663 has been researched along with valerylsalicylate in 2 studies
| Studies (mk 0663) | Trials (mk 0663) | Recent Studies (post-2010) (mk 0663) | Studies (valerylsalicylate) | Trials (valerylsalicylate) | Recent Studies (post-2010) (valerylsalicylate) |
|---|---|---|---|---|---|
| 549 | 173 | 265 | 24 | 0 | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aggarwal, S; Bhateja, D; Dhull, DK; Dhull, RK; Jindal, A; Padi, SS | 1 |
| Bhateja, D; Dhull, DK; Dhull, RK; Padi, SS | 1 |
2 other study(ies) available for mk 0663 and valerylsalicylate
| Article | Year |
|---|---|
Neuroprotective effect of cyclooxygenase inhibitors in ICV-STZ induced sporadic Alzheimer's disease in rats.
Topics: Alzheimer Disease; Animals; Antibiotics, Antineoplastic; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Etoricoxib; Injections, Intraventricular; Lipid Peroxidation; Male; Neuroprotective Agents; Pyridines; Rats; Rats, Wistar; Salicylates; Streptozocin; Sulfones | 2012 |
Differential role of cyclooxygenase isozymes on neuronal density in hippocampus CA1 region of intracerebroventricular streptozotocin treated rat brain.
Topics: Animals; CA1 Region, Hippocampal; Cell Survival; Cyclooxygenase Inhibitors; Etoricoxib; Male; Neurons; Phenacetin; Prostaglandin-Endoperoxide Synthases; Pyridines; Rats; Rats, Wistar; Salicylates; Streptozocin; Sulfones | 2012 |